21 CFR Part 11,FDA,surveillance,Validation,Pharmac 2012 - Live webinar on Best Practices for Preparation for, Behavior during, and Response to an FDA Inspection By compliance2go
Date2012-07-10
Deadline2012-07-10
Venuehouston, USA - United States
Keywords21 CFR Part 11,FDA,surveillance,Validation,Pharmaceutical, Compliance Training, conference, e-learning, Biotech, Electronic records
Topics/Call fo Papers
Does the FDA call in advance or just show up at my door? Where do I let the inspector go? Do I give them a tour? What should I let them see? Who should I let them talk to? Are they ever going to leave? The FDA inspection is the most nerve-wracking event in the life of a regulatory professional - you're in charge of compliance, usually in the background, and NOW you're in the spotlight, and if your performance isn't good, it's not the show that may close, it's YOUR COMPANY! However, adequate planning, training, composure, and understanding should result in many encore presentations! This session will discuss how to prepare for the inspection, what to do during the inspection and the close-out interview, and how to respond to the inspection. Also contained in this session will be the limits of FDA's scope during an inspection, including what documents you are not required to show them, and the permissibility of photographs and affidavits
Areas Covered in the Session:
How to prepare for an FDA inspection
Development and contents of an SOP for FDA inspection
Personnel training before inspection
How to behave during an inspection
Limitations of scope of inspection
Response to investigation findings
FDA guidance documents used by their inspectors
Webinar Includes:
-Q/A Session with the Expert to ask your question
-PDF print only copy of PowerPoint slides
-60 Minutes Live Presentation
Who will benefit: The designations
This webinar will provide valuable assistance to all companies that market in the U.S., since they are by definition subject to FDA regulation, in the Medical Device, Diagnostic, Pharmaceutical, and Biologics fields. The employees who will benefit include:
Executive/senior management
Regulatory management
QA management
Any personnel who may have direct interaction with FDA officials
Consultants
Quality system auditors
About Speaker
Jeff Kasoff, RAC, is the Director of Quality at Byrne Medical, a leading manufacturer of endoscopy products. In this position, Jeff is responsible for supplier management, during which he oversees supplier management, CAPA, and document control. Prior to this, Jeff spent 13 years at Life-Tech as the Director of Regulatory Affairs, where he was responsible for regulatory compliance of all aspects of the quality system. Jeff received his regulatory affairs certification in 1996.
Areas Covered in the Session:
How to prepare for an FDA inspection
Development and contents of an SOP for FDA inspection
Personnel training before inspection
How to behave during an inspection
Limitations of scope of inspection
Response to investigation findings
FDA guidance documents used by their inspectors
Webinar Includes:
-Q/A Session with the Expert to ask your question
-PDF print only copy of PowerPoint slides
-60 Minutes Live Presentation
Who will benefit: The designations
This webinar will provide valuable assistance to all companies that market in the U.S., since they are by definition subject to FDA regulation, in the Medical Device, Diagnostic, Pharmaceutical, and Biologics fields. The employees who will benefit include:
Executive/senior management
Regulatory management
QA management
Any personnel who may have direct interaction with FDA officials
Consultants
Quality system auditors
About Speaker
Jeff Kasoff, RAC, is the Director of Quality at Byrne Medical, a leading manufacturer of endoscopy products. In this position, Jeff is responsible for supplier management, during which he oversees supplier management, CAPA, and document control. Prior to this, Jeff spent 13 years at Life-Tech as the Director of Regulatory Affairs, where he was responsible for regulatory compliance of all aspects of the quality system. Jeff received his regulatory affairs certification in 1996.
Other CFPs
- Live webinar on 21 CFR Part 11 Add-On Inspections by the FDA By compliance2go
- Last chance to register on Best Practices for Medical Device Reporting (MDR), Recall, Reports of Corrections and Removals By compliance2go
- Last Chance to Register on Effective Root Cause Analysis and CAPA Program By compliance2go
- Live webinar on US Pharmaceutical vs Device Clinical Development: Similarities and Differences Explored By compliance2go
- Live webinar on FDA Inspections Preparation and Management By Compliance2go
Last modified: 2012-06-12 00:24:59